RESUMO: Morbid obesity is a global public health issue associated with serious medical complications such as type 2 diabetes, hypertension, and cardiovascular diseases. This study aimed to conduct a quantitative and qualitative analysis of Roux-en-Y gastric bypass (RYGB) in patients with morbid obesity over the period from 2014 to 2024. Using a comprehensive bibliographic review, databases such as Scielo, Google Scholar, scientific journals, repositories, and virtual libraries in multiple languages were consulted. The selection of studies followed rigorous inclusion and exclusion criteria to ensure relevance and methodological quality. The results showed that RYGB provides significant and sustained weight loss, along with substantial improvements in associated comorbidities such as remission of type 2 diabetes and reduction in blood pressure. However, complications and nutritional deficiencies were observed, highlighting the need for rigorous postoperative monitoring. Critical analysis of the selected studies emphasized the importance of preoperative evaluation and multidisciplinary follow-up to optimize outcomes. It is concluded that RYGB is an effective and reliable surgical intervention for morbid obesity, with significant benefits in weight loss and comorbidity management, despite associated risks. This study contributes to the existing literature by providing a detailed synthesis of the impacts of RYGB, assisting in informed clinical decision-making for the treatment of morbid obesity.
ISBN registrado: 978-65-982433-7-1
Veiculação: Digital
Revista não indexada Lion
Os trabalhos que foram submetidos e aceitos, estão nos anais do evento do primeiro CONSIS.
Comissão Organizadora
Editora Lion e Nmed cursos